OBJECTIVE: To review published clinical information on the systemic adverse effects of
ophthalmic β-blockers for the purpose of developing a pilot contraindication/warning system …

The success of medical treatment for the management of glaucoma depends largely on
patients' compliance with the treatment regimen. Ophthalmic topical beta blockers have had …

Systemic β‐blockade after single doses of ophthalmic β‐blockers (one drop in each eye)
was investigated in healthy volunteers in two randomized, double‐blind, crossover, placebo …

PURPOSE: To study the associations between long-term and short-term use of topical β-
blockers and mortality. DESIGN: Prospective population-based cohort study …

BACKGROUND Several ocular side effects including uveitis, have been reported following
topical β blocker treatment for glaucoma and ocular hypertension. The incidence of these …

Objectives: Topical β-blockers are contraindicated in obstructive pulmonary diseases
(OPDs). In this study we aimed to evaluate through central or local electronic medical …

PURPOSE: To present an evidence-based review of the systemic adverse effects of beta-
adrenergic blockers and recommend safety guidelines for use of ophthalmic beta …

At the time of their introduction, nearly 10 years ago, ophthalmic beta blockers offered an
alternative to other topical agents such as pilocarpine or epinephrine in the treatment of …

Rationale, aims, and objectives Despite recommendations in prevailing guidelines to avoid
the use of non‐selective (NS) β‐blockers in patients with asthma or COPD, on average, 10 …

This set of Viewpoints articles examines the merits of beta-blockers versus other
medications as the primary drug treatment for glaucoma. Ophthalmologists must balance …